As many as 11 pharmaceutical companies have signed MoUs with the Telangana government committing an investment of about Rs 5,500 crore and creating 9,800 new jobs in the State's new pharma park --Green Pharma City, at the 22nd edition of BioAsia 2025. With these fresh commitments, the total investment in the Green Pharma City now stands at `11,100 crore, with employment opportunities exceeding 22,300.
BioAsia, the largest life sciences and health tech forum in Asia, was inaugurated by Chief Minister A Revanth Reddy on Tuesday (25th February). The other dignitaries attended the opening of the two-day conference-cum exhibition, included IT and Industries Minister Sridhar Babu, Governor of Queensland Dr Jeannette Young.
The healthcare conference, themed ‘Catalysts of Change – Expanding Global Healthcare Frontiers, Transforming Healthcare with Innovation, Collaboration and Progress’, has become a centre stage for several key investment announcements.
Telangana government also expect US drug giant MSD to explore the technology and lifesciences capabilities of Hyderabad to accelerate its growth opportunities. Additionally, Agilisium, a company based in Los Angeles, has launched its new office at RMZ Spire, Hyderabad. The company also established a Life Sciences and Innovation & Talent Development Lab.
Meanwhile, ALS, a global leader in testing, inspection, certification, and verification solutions, is establishing a state-of-the-art Bio Pharma cGMP testing lab in Genome Valley. Similarly, Meishi Pharma–A Lotus Company–is setting up its 2nd R&D centre in Hyderabad under its new Indian subsidiary, MEISHI Pharma Services Pvt Ltd.
Focusing on strategic partnerships, the Telangana government signed a Letter of Intent with the University of Queensland to collaborate on cutting-edge research, digital healthcare and AI-driven innovations.
Telangana is set to become the first hub under the Indian Digital Health Activator, a groundbreaking initiative by the World Economic Forum. This initiative aims to accelerate public-private collaboration in digital health, bridging supply and demand gaps, and creating opportunities for a robust digital health ecosystem.
Eleven leading contract research and development organizations have come together with a shared vision: to advance industry needs, collaborate with the government for a favorable regulatory environment, nurture world-class talent, and strengthen the supply chain ecosystem. This collaboration will drive innovation, facilitate knowledge sharing, and accelerate global growth.
Health Innovation Manchester, in partnership with T-Hub, will spearhead innovation in healthcare, medtech, diagnostics, and digital health solutions, enhancing patient outcomes and advancing cutting-edge healthcare solutions.